Tweet
Our site has a visitor message option, but you message is not likely to be seen. Please post to the main forum.
-
YOB 1957
DX 12/18, GS 8, 4+4 6/12 cores, LL Apex 100%, LM Apex 60%, LL Mid 50%, LMM 40%, LL Base 5%, LM <5%, Right side negative.
3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma
T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate.
7 Nodes, SV, SM, PNI, and BNI were negative.
LVI and Cribriform pattern present.
Decipher .86 High Risk.
Post Surgery PSA
3/25/19 .03. (25 days)
4/25/19 <.03. (2 months)
5/25/19 <.02 (3 months)
9/10/2019. <.02 (7 months)
11/27/2019. <.02. T < 3 (9 months)
5/19/2020. <.02 (15 months)
11/2/2020. <.02 (21 months)
5/11/2021. <.02 T <3 (27 months)
8/25/2021. <.02 T <3 (30 months)
12/6/2021. <.02 T <3 (33 months)
6/14/2022. <.02 T <3 (39 months) T=37
3 Part Modality Treatment Completed
2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
ADT - 5/19- 5/21 Eligard and Casodex.
3 Part Modality Treatment Completed
2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
ADT - 5/19- 5/21 Eligard and Casodex.
-
Duck,
I have turned off Visitor Messaging this morning for all User Groups.
Age Dx'd 57
PCa History: Father, Grandfathers
Oct16 Bx: Gleason 4+3 Grade Group 3 w/PNI
LB: 4+3 (60% pattern 4),
RA: 3+3, RLM: 3+3, RLA: 3+3
Jan 2017 RALP - Dr. Grant Taylor - Pathology = pT3a; Gleason 4+3; Weight: 42g
Jun 2019 AMS800 installed, Jul 2019 activated - Dr. David RappPSA_TESTS
Apr16-5.10
Jul16-4.70
Aug16-5.13
---Surgery---
Mar17<0.01
Jul17<0.01
Oct17<0.01
Jan18<0.01
May18<0.01
Nov18<0.01
Jan19<0.01
Jun19<0.02
Nov20<0.10
May21<0.10
Apr22<0.10
Comment